Skip to main content
Psychedex

PRO-LAD

N,N-diethyl-6-propyl-9,10-didehydroergoline-8β-carboxamide

1Provenance card

the boundary, as counts

Sources

1712 with DOI

4 strong · 9 moderate · 4 weak

Compilations

22026-04-27T07:21:33.829Z

pipeline-v5 · prompt hash not recorded — run predates 2026-09

Decisions

31last ruled 2026-06-04

0 awaiting a ruling

Issued documents

62026-10-19T20:33:45.928Z

notice · info card · emergency

Searches

253 with no results

queries and counts on the build

Claims checked

4529 supported

29 supported · 16 not

Correspondence

0received

consent field ships in Phase 4

Edges

180

derivations recorded for this entity

Complete over 17 sources, 2 compilations, and 31 decisions.Not here: the private journal (never).Working material — drafts, discards, unsupported claims — is listed below and readable on the working page.Cite: psychedex.org/substances/pro-lad/archive

Timeline

what happened, newest first — claims, searches and artifacts stay inside Build

  1. 2026-10-19issueIssued emergency
  2. 2026-10-19issueIssued info_card
  3. 2026-10-19issueIssued notice
  4. 2026-09-24srcReturn of the lysergamides. Part II: Analytical and behavioural characterization of N6-allyl-6-norlysergic acid diethylamide (AL-LAD) and (2'S,4'S)-lysergic acid 2,4-dimethylazetidide (LSZ)
  5. 2026-09-24srcReturn of the lysergamides. Part III: Analytical characterization of ETH-LAD and 1P-ETH-LAD
  6. 2026-09-24srcGenie in a blotter: A comparative study of LSD and LSD analogues' effects and user profile
  7. 2026-09-24srcThe use patterns of novel psychedelics: experiential fingerprints of substituted phenethylamines, tryptamines and lysergamides
  8. 2026-09-24srcPharmacokinetics and Pharmacodynamics of Lysergic Acid Diethylamide in Healthy Subjects
  9. 2026-09-24srcTapentadol Versus Tramadol: A Narrative and Comparative Review of Their Pharmacological, Efficacy and Safety Profiles
  10. 2026-09-24srcCrystal Structure of an LSD-Bound Human Serotonin Receptor
  11. 2026-09-24srcReceptor interaction profiles of novel psychoactive tryptamines compared with classic hallucinogens
  12. 2026-09-24srcThe polypharmacology of psychedelics reveals multiple targets for potential therapeutics
  13. 2026-09-24srcPharmacokinetics and Concentration-Effect Relationship of Oral LSD in Humans
  14. 2026-09-24srcThe pharmacology of lysergic acid diethylamide: a review
  15. 2026-09-24srcPopulation Survey Data Informing the Therapeutic Potential of Classic and Novel Phenethylamine, Tryptamine, and Lysergamide Psychedelics
  16. 2026-09-24srcSynthesis and LSD-like discriminative stimulus properties in a series of N(6)-alkyl norlysergic acid N,N-diethylamide derivatives
  17. 2026-09-24srcTiHKAL: Tryptamines I Have Known and Loved — Entry #51 PRO-LAD
  18. 2026-09-24srcPRO-LAD: The Forgotten LSD-Alternative - Tripsitter
  19. 2026-09-24srcPRO-LAD - Wikipedia
  20. 2026-09-24srcHome Office Circular 001/2015: Control of AH-7921, LSD-related compounds, tryptamines, and rescheduling of GHB
  21. 2026-09-04issueIssued emergency
  22. 2026-09-04issueIssued info_card
  23. 2026-09-04issueIssued notice
  24. 2026-06-04proposal29 value proposals approved togetherone review action inferred from a shared reviewer and instant — the graph records one activity per proposal
  25. 2026-06-04publicationPublication — backfill
  26. 2026-04-27revisionRevision 1
  27. 2026-04-27absenceSearched ClinicalTrials.gov for "PRO-LAD lysergamide" — no results
  28. 2026-04-27absenceSearched ClinicalTrials.gov for "PRO-LAD lysergamide" — no results
  29. 2026-04-27absenceSearched PubMed for "Hoffman Nichols 1985 lysergamide diethylamide psychedelic analog SAR" — no results
  30. 2026-04-27genGeneration — pipeline-v5 · with 2 morepipeline-v5
  31. 2026-04-27rungeneration run
  32. 2026-04-26rungeneration run

The same entries, as forms: six forms.